Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,294 | 0,300 | 15:05 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Implanet S.A. reports Q3 results | 4 | Seeking Alpha | ||
Di | IMPLANET Reports Q3 2025 Revenue of €2.9 Million, Up +26% | 230 | Business Wire | Nine-month 2025 revenue of €8.7 million, up +36% compared to the same period last year
U.S. activity up +22% in Q3 2025 and multiplied by 1.8x over the first nine months of 2025 (vs. 2024)... ► Artikel lesen | |
23.09. | IMPLANET Signs Exclusive Distribution Agreement with TINAVI Medical Technologies for the TiRobot Spine Surgery System | 340 | Business Wire | Strengthening the commercialization strategy for cobotic1 solutions in orthopedic surgery
Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology... ► Artikel lesen | |
IMPLANET Aktie jetzt für 0€ handeln | |||||
16.09. | IMPLANET Announces First-Half 2025 Results | 296 | Business Wire | First-half revenue up 41% to €5.8 million
16% improvement in net result from continuing operations
Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME)... ► Artikel lesen | |
15.07. | IMPLANET Announces CFDA Approval for Its Innovative JAZZ Range in China | 346 | Business Wire | Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, PEA-PME eligible), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced... ► Artikel lesen | |
08.07. | IMPLANET Announces Half-Year Revenue for 2025 up 41% to €5.8 Million | 963 | Business Wire | Second quarter 2025 up +71% to €3.2 millions
Revenue in the United States increased by a factor of 5.4 in Q2 2025 and by 1.7x for the first half of 2025 compared to 2024
Strong first... ► Artikel lesen | |
24.04. | IMPLANET to Co-Exhibit its Innovative Spine Solutions Alongside 8i Robotics' Next-Gen Robotic Solutions at AANS in Boston | 347 | Business Wire | Spine tech innovator IMPLANET will demo and display its game-changing portfolio in tandem with 8i Robotics' robot systems at Booth #1029, April 25-28, 2025
Regulatory News:
At this year's American... ► Artikel lesen | |
14.04. | Minutes of IMPLANET's Annual General Meeting Held on April 11, 2025 | 515 | Business Wire | Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, éligible PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced... ► Artikel lesen | |
09.04. | IMPLANET Reports Revenue of €2.58 Million in Q1 2025, Up +16% | 340 | Business Wire | +16% revenue growth compared to Q1 2024
Performance driven by strong export growth outside France and the United States (+42% vs. Q1 2024)
Regulatory News:
IMPLANET (Euronext Growth:... ► Artikel lesen | |
04.03. | IMPLANET Reports Its 2024 Full-Year Results | 568 | Business Wire | 2024 full-year revenue up +26% compared to fiscal year 2023
Continued strict control of operational costs throughout the period
Regulatory News:
IMPLANET (Euronext Growth: ALIMP,... ► Artikel lesen | |
14.01. | IMPLANET Announces 2024 Full-Year Revenue Up 26% to €9.4 Million | 452 | Business Wire | Continued acceleration in quarterly revenue growth since Q2 2024, with Q4 2024 reaching nearly €3.0 million, up 81% versus 2023
Strong full-year performance in the medical equipment distribution... ► Artikel lesen | |
06.01. | IMPLANET Announces Its 2025 Financial Calendar | 569 | Business Wire | Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the... ► Artikel lesen | |
05.12.24 | IMPLANET Announces Financing of Around €2 Million | 504 | Business Wire | Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 47,700 | 0,00 % | PTA-Adhoc: PORR AG: PORR vereinbart Erwerb des österreichischen Projektentwicklungsgeschäfts und Thermenbeteiligungen von Fresenius/VAMED | DJ PTA-Adhoc: PORR AG: PORR vereinbart Erwerb des österreichischen Projektentwicklungsgeschäfts und Thermenbeteiligungen von Fresenius/VAMED
Veröffentlichung von Insiderinformationen gemäß Artikel... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,380 | +0,36 % | Siemens Healthineers: Was folgt auf die Bärenfalle? | Als Donald Trump verkündete, er werde auf Importe von Medizinprodukten und Medikamenten 100 Prozent Zoll verhängen, brach erst einmal alles ein, was diesem Bereich zuzurechnen ist, auch Siemens Healthineers.... ► Artikel lesen | |
INTUITIVE SURGICAL | 376,25 | +1,70 % | ISRG Shares Rise as FDA Clears AI Integration for Ion Platform | ||
BICO GROUP | 1,959 | -0,31 % | BICO Group AB: Maria Rankka appointed Board Chair of BICO Group AB | The Board of Directors has with immediate effect among its members elected Maria Rankka to serve as Board Chair of BICO Group AB, until a new chair has been elected by the shareholders' meeting. Maria... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,108 | -2,70 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
NUGEN MEDICAL DEVICES | 0,030 | -5,66 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
HEALWELL AI | 0,870 | -0,40 % | HEALWELL veröffentlicht Unternehmens-Update zu den Integrationsfortschritten und zur weltweiten Einführung von AmadeusAI, seiner KI-gestützten digitalen Gesundheitsakte der nächsten Generation | - HEALWELL erzielt einen bemerkenswerten Meilenstein in Sachen Integration und gibt die weltweite Markteinführung von AmadeusAI bekannt, das nun tief in DARWEN AI eingebettet
ist und... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,907 | -7,07 % | Atossa Therapeutics Inc: Atossa Therapeutics Streamlines EVANGELINE Breast Cancer Clinical Trial to Prioritize for 2026 NDA-Enabling Activities | Changes are expected to reduce future study costs, accelerate objective readouts, and extend operating runway under current plans
SEATTLE, Oct. 6, 2025 /PRNewswire/... ► Artikel lesen | |
OTTOBOCK | 67,85 | -0,95 % | Ottobock: Hohe Nachfrage - weitere Details zum IPO | Der Prothesenhersteller Ottobock will in dieser Handelswoche das Listing an der Frankfurter Wertpapierbörse final unter Dach und Fach bringen. Und die Chancen stehen sehr gut, dass das Unternehmen am... ► Artikel lesen | |
PING AN HEALTHCARE | 1,847 | 0,00 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Appoints Michael Guo as Chairman of the Board and He Mingke as CEO | HONG KONG and SHANGHAI, Oct. 9, 2025 /PRNewswire/ -- The board of directors (the "Board") of Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or the "Company"... ► Artikel lesen | |
NETRAMARK | 0,780 | -2,50 % | AMD, NetraMark, Adobe - KI-Nachzügler mit deutlichem Aufholpotenzial | Aktuell wird am Markt heiß diskutiert, wann die KI-Bubble endlich platzen wird. Die Nervosität der Anleger nimmt zu, schließlich liegen die Bewertungen vieler Unternehmen wie Palantir oder Nvidia auf... ► Artikel lesen | |
EMEIS | 15,230 | +2,08 % | emeis: Results for the first half of 2025 | Confirmed recovery trajectory
Free Cash Flow turned positive
Disposals targets now exceeded
New mid term outlook
Regulatory News:
This press release features multimedia. View the full release... ► Artikel lesen | |
INSULET | 272,90 | +0,74 % | Insulet Opens Global Capability Center in Guadalajara | ||
CYTOSORBENTS | 0,800 | +2,17 % | CytoSorbents Corporation: CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR | FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization... ► Artikel lesen | |
CLARIANE | 4,564 | +1,88 % | Jetzt bewerben! Korian Stiftungsaward für Vielfalt und Respekt in der Pflege 2026 | München (ots) - Die gemeinnützige Korian Stiftung für Pflege und würdevolles Altern schreibt zum sechsten Mal den Korian Stiftungsaward für Vielfalt und Respekt in der Pflege aus. Mit dem Preis zeichnet... ► Artikel lesen |